Retrospective study identifies potential for misdiagnosed mycosis fungoides and for dupilumab to fuel cutaneous lymphoid reactions that mimic mycosis fungoides in patients with atopic dermatitis.
MARSEILLE, France, October 05, 2023 Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has placed a partial clinical hold on the lacutamab IND leading to a pause in new patient enrollment to the Company’s ongoing lacutamab trials IPH4102-201 (Phase 2 TELLOMAK) and 102 (Phase 1b PTCL). The partial clinical hold follows one fatal case of hemophagocytic lymphohistiocytosis (HLH), a rare
Washington, DC, Aug. 12, 2023 (GLOBE NEWSWIRE) Zion Market Research has published a new research report titled "Telecom Cloud Billing Market Size By Application (Account Management, Revenue Management, And Customer
[212 + Pages Research Study] According to a market research study published by Zion Market Research, the demand analysis of Global Telecom Cloud Billing.
James "Jimmy" Green, a Miami-Dade Fire Rescue firefighter and paramedic of 18 years is not only battling a rare and aggressive form of skin cancer, but a.